°í½Å´ëº´¿ø Á¦24Â÷ ¿µ³²³»°ú°è½ÅÀåÀ̽Ŀ¬±¸È¸ ÇмúÁý´ãȸ : 2019-11-02±³À°ÀÏÀÚ : 2019-11-02
±³À°Àå¼Ò : °í½Å´ëº´¿ø 6µ¿ 5Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦24Â÷ ¿µ³²³»°ú°è½ÅÀåÀ̽Ŀ¬±¸È¸ ÇмúÁý´ãȸÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ³²³»°ú°è½ÅÀÌ½Ä ¿¬±¸È¸
´ã´çÀÚ : °¼±¿ì
¿¬¶ôó : 02-000-0000
À̸ÞÀÏ :
kswnephrology@gmail.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-02 ´ë°´ç 15:00~15:25 CMV, Guidelines & Personalized Medicine: Immunodiagnostics, Immunosuppression Á¤Èñ¿¬(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-02 ´ë°´ç 15:25~15:50 Novel Therapies: Medications, Vaccines, and Management of Resistant Virus ¹Ú°æ¼±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-02 ´ë°´ç 15:50~16:15 Outcomes of difference between old donors and young donors ±è¿¹¸²(°è¸íÀÇ´ë)
±³À°½Ã°£ 11-02 ´ë°´ç 16:15~16:40 What is survival Prognostic Factors in Elderly Recipients of Kidney Transplantation À̵¿¿(ºÀ»ýº´¿ø)
Åä·Ð 11-02 ´ë°´ç 16:40~17:00 ÁúÀÇ ¹× ÅäÀÇ ()
±³À°½Ã°£ 11-02 ´ë°´ç 17:00~17:20 ½ÅÀåÀ̽ÄȯÀÚ Áõ·Ê1 ±è¿ëÁø(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-02 ´ë°´ç 17:20~17:40 ½ÅÀåÀ̽ÄȯÀÚ Áõ·Ê2 ±è¿ëÁø(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-02 ´ë°´ç 17:40~18:00 ½ÅÀåÀ̽ÄȯÀÚ Áõ·Ê3 ±è¿ëÁø(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-02 ´ë°´ç 18:00~18:20 ½ÅÀåÀ̽ÄȯÀÚ Áõ·Ê4 ±è¿ëÁø(°æºÏÀÇ´ë)
Åä·Ð 11-02 ´ë°´ç 18:20~18:40 ÁúÀÇ ¹× ÅäÀÇ ()